Cargando…

Precision Medicine in Pancreatic Ductal Adenocarcinoma: The Impact of Targeted Therapies on Survival of Patients Harboring Actionable Mutations

Background: Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of death by cancer worldwide. Mostly diagnosed with locally advanced or metastatic disease, patients lack treatment options. Gene alterations (GAs) are frequently observed in PDAC, some of which are considered for molecul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tarabay, Anthony, Boileve, Alice, Smolenschi, Cristina, Antoun, Leony, Valery, Marine, Fuerea, Alina, Perret, Audrey, Burtin, Pascal, Cosconea, Simona, Belkhodja, Hichem, Malka, David, Boige, Valérie, Hollebecque, Antoine, Ducreux, Michel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526242/ https://www.ncbi.nlm.nih.gov/pubmed/37761010 http://dx.doi.org/10.3390/biomedicines11092569

Ejemplares similares

Targetable Molecular Alterations in the Treatment of Biliary Tract Cancers: An Overview of the Available Treatments
por: Valery, Marine, et al.
Publicado: (2023)

Immunotherapy and Hepatocellular Cancer: Where Are We Now?
por: Valery, Marine, et al.
Publicado: (2022)

Immunotherapy in Advanced Biliary Tract Cancers
por: Boilève, Alice, et al.
Publicado: (2021)

Molecular targeted therapy of BRAF-mutant colorectal cancer
por: Ducreux, Michel, et al.
Publicado: (2019)

Implementing patient derived organoids in functional precision medicine for patients with advanced colorectal cancer
por: Cartry, Jérôme, et al.
Publicado: (2023)

No evidence for changes in skeletal muscle mass or weight during first-line chemotherapy for metastatic colorectal cancer
por: Antoun, Sami, et al.
Publicado: (2019)

Tumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II–III colorectal cancer
por: Chaput, N, et al.
Publicado: (2013)

Safety and Efficacy of Bevacizumab in Cancer Patients with Inflammatory Bowel Disease
por: Herrera-Gómez, Ruth Gabriela, et al.
Publicado: (2022)

Evaluation of subsurface transport processes of delayed gas signatures applicable to underground nuclear explosions
por: Carrigan, Charles R., et al.
Publicado: (2022)

Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial – PACHA-01 (NCT02494973)
por: Goéré, Diane, et al.
Publicado: (2018)

Iron deficiency across chronic kidney disease stages: Is there a reverse gender pattern?
por: Aoun, Mabel, et al.
Publicado: (2018)

La piel de los dedos
por: Belkhodja, Katia

Reduction of intracerebral hemorrhage in hemodialysis patients after reducing aspirin use: A quality-assurance observational study
por: Aoun, Mabel, et al.
Publicado: (2017)

Applied precision medicine in metastatic pancreatic ductal adenocarcinoma
por: Taghizadeh, Hossein, et al.
Publicado: (2020)

Recent advances in precision medicine for pancreatic ductal adenocarcinoma
por: Hayashi, Hiromitsu, et al.
Publicado: (2021)

Non Hodgkin lymphoma in Lebanon: a retrospective epidemiological study between 1984 and 2019
por: Touma, Elsie, et al.
Publicado: (2021)

Spall fracture
por: Antoun, Tarabay, et al.
Publicado: (2003)

Multicentre phase II trial of capecitabine plus oxaliplatin (XELOX) in patients with advanced hepatocellular carcinoma: FFCD 03-03 trial
por: Boige, V, et al.
Publicado: (2007)

Preclinical models of pancreatic ductal adenocarcinoma: challenges and opportunities in the era of precision medicine
por: Yu, Yiqi, et al.
Publicado: (2021)

Phase I trial of oxaliplatin with fluorouracil, folinic acid and concurrent radiotherapy for oesophageal cancer
por: Conroy, T, et al.
Publicado: (2008)

Molecular Landscape of Therapy-related Myeloid Neoplasms in Patients Previously Treated for Gynecologic and Breast Cancers
por: Khalife-Hachem, Sabine, et al.
Publicado: (2021)

Predicting immunotherapy outcomes in patients with MSI tumors using NLR and CT global tumor volume
por: Belkouchi, Younes, et al.
Publicado: (2022)

No safe harbor.
por: Holton, W C
Publicado: (1998)

Low-Frequency Mutational Heterogeneity of Invasive Ductal Carcinoma Subtypes: Information to Direct Precision Oncology
por: Myers, Meagan B., et al.
Publicado: (2019)

Long-lived pancreatic ductal adenocarcinoma slice cultures enable precise study of the immune microenvironment
por: Jiang, Xiuyun, et al.
Publicado: (2017)

Ex vivo organotypic culture system of precision-cut slices of human pancreatic ductal adenocarcinoma
por: Misra, Sougat, et al.
Publicado: (2019)

Refining pancreatic ductal adenocarcinoma molecular subtype and precision therapeutics with single-nucleus RNA-seq
por: He, Lishu
Publicado: (2021)

Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: Role of the Radiologist and Oncologist in the Era of Precision Medicine
por: Vernuccio, Federica, et al.
Publicado: (2021)

Kras mutation rate precisely orchestrates ductal derived pancreatic intraepithelial neoplasia and pancreatic cancer
por: Singh, Kanchan, et al.
Publicado: (2020)

Precision measurements of $\Gamma$(Z --> b$\overline{b}$)
por: Perret, P
Publicado: (1993)

Building Trust to Encourage Vaccination: The Infection Preventionist's Role with Vaccine Compliance
por: Tarabay, Jessica
Publicado: (2022)

Next-generation androgen receptor inhibitors in non-metastatic castration-resistant prostate cancer
por: Lavaud, Pernelle, et al.
Publicado: (2020)

Local and Systemic Cytokine Profiling for Pancreatic Ductal Adenocarcinoma to Study Cancer Cachexia in an Era of Precision Medicine
por: Gerber, Michael H., et al.
Publicado: (2018)

Correction to: Kras mutation rate precisely orchestrates ductal derived pancreatic intraepithelial neoplasia and pancreatic cancer
por: Singh, Kanchan, et al.
Publicado: (2021)

Precision and Disclosure in Text and Voice Interviews on Smartphones
por: Schober, Michael F., et al.
Publicado: (2015)

An update on treatment options for pancreatic adenocarcinoma
por: Lambert, Aurélien, et al.
Publicado: (2019)

Synergizing liver systemic treatments with interventional oncology: friend or foe?
por: Jost, Raphaël, et al.
Publicado: (2022)

Genome-wide transcriptome profiling of ex-vivo precision-cut slices from human pancreatic ductal adenocarcinoma
por: Ghaderi, Mehran, et al.
Publicado: (2020)

The overexpression of DNA repair genes in invasive ductal and lobular breast carcinomas: Insights on individual variations and precision medicine
por: Mohamed, Ruwaa I., et al.
Publicado: (2021)

Treatment intensification with hepatic arterial infusion chemotherapy in patients with liver-only colorectal metastases still unresectable after systemic induction chemotherapy – a randomized phase II study -- SULTAN UCGI 30/PRODIGE 53 (NCT03164655)- study protocol
por: Boilève, Alice, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_eic0lfigqb3565na7gc0jrdv91